Trandolapril | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Trandolapril
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Trandolapril

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 8 USDMF, 6 CEP/COS, 3 JDMF, 2 EU WC, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

15 API Suppliers
8 USDMF
6 CEP/COS
3 JDMF
2 EU WC
4 NDC API
6 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 33 FDA Orange Book, 8 Europe, 29 Canada, 24 Australia, 8 South Africa, 4 Listed Dossiers

106 FDF Dossiers
33 FDA Orange Book
8 Europe
29 Canada
24 Australia
8 South Africa
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 4 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 28 Controlled & Modified Release, 22 Direct Compression, 21 Disintegrants & Superdisintegrants, 20 Granulation, 19 Thickeners and Stabilizers, 19 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Solubilizers, 9 Film Formers & Plasticizers, 8 Topical, 8 Chewable & Orodispersible Aids, 7 Taste Masking, 6 Parenteral, 5 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 1 Surfactant & Foaming Agents

67 Fillers, Diluents & Binders
47 Coating Systems & Additives
28 Controlled & Modified Release
22 Direct Compression
21 Disintegrants & Superdisintegrants
20 Granulation
19 Thickeners and Stabilizers
19 Lubricants & Glidants
13 Co-Processed Excipients
12 Solubilizers
9 Film Formers & Plasticizers
8 Topical
8 Chewable & Orodispersible Aids
7 Taste Masking
6 Parenteral
5 API Stability Enhancers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Emulsifying Agents
4 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Finished Drug Prices

1 US Medicaid Prescriptions
17 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 6 Others

3 EDQM
2 USP
6 Others

$ API Ref.Price (USD/KG) : 4,920 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 3Abbott Laboratories Limited

02 1BGP Pharma Inc.

03 3BGP Pharma ULC

filter Patent Reset all filters

7 All

01 41341206

02 31341296

filter Product Reset all filters

7 All

01 7Trandolapril

filter Dosage Reset all filters

7 All

01 7Capsule

filter Exp Date Reset all filters

7 All

01 42018-03-20

02 32018-09-25

Product Main Page

01

Abbott Laboratories Limited

Trandolapril

PharmScience R&D

Not Confirmed

Abbott Laboratories Limited

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 1 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Abbott Laboratories Limited

Trandolapril

PharmScience R&D

Not Confirmed

Abbott Laboratories Limited

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 2 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Abbott Laboratories Limited

Trandolapril

PharmScience R&D

Not Confirmed

Abbott Laboratories Limited

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 4 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BGP Pharma ULC

Trandolapril

PharmScience R&D

Not Confirmed

BGP Pharma ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 0.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BGP Pharma Inc.

Trandolapril

PharmScience R&D

Not Confirmed

BGP Pharma Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Trandolapril

Brand Name : MAVIK

Patent Number : 1341206

Filing Date : 1981-10-20

Strength per Unit : 0.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-20

Date Granted : 2001-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BGP Pharma ULC

Trandolapril

PharmScience R&D

Not Confirmed

BGP Pharma ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 1 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BGP Pharma ULC

Trandolapril

PharmScience R&D

Not Confirmed

BGP Pharma ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Trandolapril

Brand Name : MAVIK

Patent Number : 1341296

Filing Date : 1982-12-23

Strength per Unit : 2 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-09-25

Date Granted : 2001-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!